Planned HICPAC/CDC revisions will water down infection control protections, particularly for aerosol transmission, endangering healthcare workers and patients.
Category: Forbes
CDC Poised To Weaken Masking, Infection Control
Planned HICPAC/CDC revisions will water down infection control protections, particularly for aerosol transmission, endangering healthcare workers and patients.
This Startup Just Raised $60 Million To Help Cancer Patients Navigate Their Care
Thyme Care is helping around 3,000 patients and plans to use the funds to scale its value-based care model.
Nearly Half Of Americans Polled Want Weight Loss Drugs But Many Lose Interest After Reading The Fine Print
While the market for weight loss drugs has potential, questions are raised concerning the drugs’ route of administration, side effect profile, cost and lack of coverage.
Google Is Rapidly Becoming A Healthcare Powerhouse
Google’s footprint in healthcare is extensive, ranging from developing cutting-edge hardware and diagnostic tools to enabling Cloud modernization and access to health information.
West Virginia Says It’s Too Poor To Support Its Only Major University
A couple of weeks ago, the president of West Virginia University, Gordon Gee, announced a set of truly draconian cuts: he’s firing 169 faculty, about 16% of the full-t…
The Changing Face Of Healthcare: The Rise Of The Middlemen
Today’s Frankenstein healthcare is populated—no, overrun—with middlemen, actors and sub-actors who promise to fill perceived gaps in the healthcare system.
How Vivek Ramaswamy Became A Billionaire
The whip-smart Republican is one of the richest thirty-somethings in America. Unlike Donald Trump, he’s entirely self-made.
It’s Time To End the PBM Shakedown
By shining a light on PBMs’ questionable business practices, and potentially cracking down on some of their anticompetitive behavior, lawmakers can help patients fill their prescriptions without breaking the bank.
On 1-Year Anniversary Of Inflation Reduction Act’s Signing, Impact On Drug Prices And Out-Of-Pocket Spending Still To Be Determined
On the one-year anniversary of the IRA’s signing, most of the bill’s impact on drug prices and Medicare beneficiary out-of-pocket spending has yet to be determined.
